Institutional investors purchased a net $25.0 million shares of GERN during the quarter ended September 2013 and now own 50.16% of the total shares outstanding. This majority interest is a greater percentage than is typical for companies in the Biotechnology industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
FIDELITY MANAGEMENT & RESEARCH C... Bought 16.0 Million shares of Geron Corp
SSGA FUNDS MANAGEMENT, INC. Bought 3.5 Million shares of Geron Corp
CORMORANT ASSET MANAGEMENT LLC Bought 3.4 Million shares of Geron Corp